Related Experiment Videos
Use of nafarelin for testing pituitary-ovarian function
R L Rosenfield1, S Burstein, L Cuttler
1Pritzker School of Medicine, University of Chicago, Illinois.
The Journal of Reproductive Medicine
|December 1, 1989
Summary
A single dose of nafarelin effectively assesses pituitary-ovarian function across all ages, from infancy to adulthood. This method provides a reliable test for reproductive health throughout development.
Area of Science:
- Reproductive endocrinology
- Pediatric endocrinology
- Gynecology
Background:
- Pituitary-ovarian function is crucial for reproductive health.
- Accurate assessment is vital from infancy through maturity.
- Existing methods may have limitations across age groups.
Purpose of the Study:
- To evaluate nafarelin's utility in testing pituitary-ovarian function.
- To determine if a single dose is sufficient for assessment.
- To establish nafarelin's applicability across a wide age range.
Main Methods:
- Administration of a single dose of nafarelin.
- Monitoring of hormonal responses indicative of pituitary-ovarian activity.
- Evaluation across subjects from infancy to adulthood.
Main Results:
- Nafarelin demonstrated efficacy in testing pituitary-ovarian function.
- The single-dose approach was effective across the studied age spectrum.
- Results indicate reliable assessment from infancy through maturity.
Conclusions:
- A single dose of nafarelin serves as a viable and effective test for pituitary-ovarian function.
- This method is applicable and reliable throughout the lifespan, from infancy to adulthood.
- Nafarelin offers a valuable tool for assessing reproductive endocrine status.